Author:
Follath F.,Spring P.,Vozeh S.,Wenk M.
Reference25 articles.
1. Barza, M., and Lauerman, M.: Why monitor serum levels of gentamicin? Clin. Pharmacokinetics: 3: 202–215 (1978)
2. Broughton, A., Strong, J. E., Pickering, L. K., and Bodey, G. P.: Radioimmunoassay of iodimated tobramycin. Antimicrob. Agents Chemother.: 10: 652–656 (1976)
3. Broughton, A., Strong, J. E., Pickering, L. K., Knight, J., and Bodey, G. P.: Radioimmunoassay and radioenzymatic assay of a new aminoglycoside antibiotic, netilmicin. Clin. Chem.: 24: 717–719 (1978)
4. Chauvin, J. M., Rudhardt, M., Blanchard, P., Gaillard, R., and Fabre, J.: Le comportement de la gentamicine dans le parenchyme rénale. Schweiz. Med. Wschr.: 108: 1020–1025 (1978)
5. Colburn, W. A., Schentag, J. J., Jusko, W. J., and Gibaldi M.: A model for prospective identification of the prenephrotoxic state during gentamicin therapy. J. Pharmacokin. Biopharm.: 6: 179–186 (1978)